What is the intrinsic value of SUPN?

As of 2025-07-12, the Intrinsic Value of Supernus Pharmaceuticals Inc (SUPN) is 41.90 USD. This SUPN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 33.12 USD, the upside of Supernus Pharmaceuticals Inc is 26.50%.

The range of the Intrinsic Value is 27.65 - 99.53 USD

Is SUPN undervalued or overvalued?

Based on its market price of 33.12 USD and our intrinsic valuation, Supernus Pharmaceuticals Inc (SUPN) is undervalued by 26.50%.

	Range	Selected	Upside
a
DCF (Growth 5y)	27.65 - 99.53	41.90	26.5%
DCF (Growth 10y)	35.67 - 122.92	53.04	60.1%
DCF (EBITDA 5y)	15.50 - 26.44	20.50	-38.1%
DCF (EBITDA 10y)	21.47 - 34.66	27.35	-17.4%
Fair Value	27.64 - 27.64	27.64	-16.53%
P/E	12.92 - 28.78	20.59	-37.8%
EV/EBITDA	13.27 - 34.08	21.50	-35.1%
EPV	39.06 - 47.53	43.30	30.7%
DDM - Stable	11.34 - 50.91	31.13	-6.0%
DDM - Multi	20.31 - 72.57	31.94	-3.6%